Tag: Inmed pharmaceuticals
InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids
InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
InMed Pharmaceuticals and BayMedica Announce Collaboration for Manufacturing and Testing of Novel Cannabinoid Therapeutics
InMed Pharmaceuticals Reports First Quarter Fiscal 2021 IFRS Financial Results
InMed Pharmaceuticals Reports Full Year Fiscal 2020 Financial Results and Provides Business Update
